… bempedoic acid, and 2% received a combination of Ezetimibe and bempedoic acid. No patients were initiated on PCSK9 inhibitors.Abstract 7-007 …
PCSK9 inhibitors
This drug is selected. Its supporting articles are shown below.
Articles mentioning PCSK9 inhibitors
6 articles · page 1 of 1… long-term dual antithrombotic therapy (low-dose rivaroxaban or ticagrelor). This study compared cardiovascular outcomes of patients seen …
…h individual and combination LLT, including statins, ezetimibe, bempedoic acid, and PCSK9 inhibitors. Admission lipid profile and pre-ACS LLT …
…resource-limited settings. Pharmacological innovations, such as PCSK9 inhibitors, inclisiran and agents targeting lipoprotein(a) and inflammatio…
…nce LDL-C levels and CC-IMT, in keeping with proven benefits of PCSK9 inhibitors on atherosclerotic cardiovascular events.…
…80 mg or equivalent on admission 88.15%(n=67)93.8% (n=61)p=0.22 Ezetimibe 10 mg on admission 65.7%(n=50)73.8% (n=48)p=0.56 PCSK9 inhibito…